Answers are grounded in this paper and cite their sources.
In overseas reports, temporomandibular disorders (TMDs) are said to affect 5–12% of the population, and the number of TMD patients seeking treatment in Korea is on the rise. Even though Korean medicine (KM) treatments are commonly used for TMDs in clinical practice, clinical practice guidelines (CPGs) for TMDs in traditional KM have not yet been established. This evidence-based KM CPG on TMDs was therefore established. The key questions of the KM CPG on TMDs were determined based on clinical practice surveys on the use of KM for TMDs and expert opinion from the relevant academic societies by the CPG development committee. Then, a systematic literature review of KM treatments for TMDs was conducted for each key question, and the guideline draft was created in accordance with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) levels of evidence and grades of recommendation. Official consensus was achieved using the Delphi method on the draft, and the draft was further revised through external review to produce the final guideline, which was certified by the relevant academic societies. A total of 15 recommendations are established to address the 13 key clinical questions about the clinical efficacy of 9 types of KM treatments for TMD, including grades and levels of evidence. The present guideline is expected to aid in the decision-making process of physicians and TMD patients, improve the overall quality of KM practice, and suggest subjects for future clinical research.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: